In 2019, Wei et al. found that 17β-estradiol exerted anticancer effects in HCC by targeting the NLRP3 inflammasome however, its precise role in HCC development remains to be investigated [13]. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.